Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Application of Machine Learning for Diagnosis of Psychiatric Diseases

FY 2018-19

Summary
Neuropsychiatric diseases are disorders of the brain, which include schizophrenia, mood disorders, and autism. Despite many years of research, treatment for these diseases is still suboptimal, and the prevalence of these diseases has not decreased. A challenge in diagnosing and addressing these diseases is the diverse set of causes and risk factors unique to a patient even though different patients share similar symptoms. For this reason, it is also difficult to predict a patient’s response to treatment. Our approach to addressing this challenge is to identify and group patients that are similar at a biochemical level which could facilitate the identification of a common cause of illness for the patients grouped together. We plan to do this by applying computational methods such as clustering algorithms to the genetic, metabolic and other functional data from patients. By stratifying patients into similar groups, we can improve the diagnostic process, the monitoring and the management of these patients, as well as identify novel targeted treatments for their conditions.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
418722
Name
Qi Lin
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Application of Machine Learning for Diagnosis of Psychiatric Diseases
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Biomarkers; Clustering Algorithms; Diagnosis; Genomics; Machine Learning; Metabolomics; Psychiatric Disease
Abstract
Neuropsychiatric diseases are disorders of the brain, which include schizophrenia, mood disorders, and autism. Despite many years of research, treatment for these diseases is still suboptimal, and the prevalence of these diseases has not decreased. A challenge in diagnosing and addressing these diseases is the diverse set of causes and risk factors unique to a patient even though different patients share similar symptoms. For this reason, it is also difficult to predict a patient’s response to treatment. Our approach to addressing this challenge is to identify and group patients that are similar at a biochemical level which could facilitate the identification of a common cause of illness for the patients grouped together. We plan to do this by applying computational methods such as clustering algorithms to the genetic, metabolic and other functional data from patients. By stratifying patients into similar groups, we can improve the diagnostic process, the monitoring and the management of these patients, as well as identify novel targeted treatments for their conditions.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Qi, Lin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~